Cargando…

Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin

The clinical characteristics and vascular computed tomography (CT) imaging characteristics of patients were explored so as to assist clinicians in diagnosing patients with atherosclerosis. 316 patients with atherosclerosis who were hospitalized for emergency treatment were treated with rapamycin (RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Fuguang, Zhou, Shuai, Bi, Zhangshuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321726/
https://www.ncbi.nlm.nih.gov/pubmed/34336152
http://dx.doi.org/10.1155/2021/4543702
_version_ 1783730913149976576
author Ji, Fuguang
Zhou, Shuai
Bi, Zhangshuan
author_facet Ji, Fuguang
Zhou, Shuai
Bi, Zhangshuan
author_sort Ji, Fuguang
collection PubMed
description The clinical characteristics and vascular computed tomography (CT) imaging characteristics of patients were explored so as to assist clinicians in diagnosing patients with atherosclerosis. 316 patients with atherosclerosis who were hospitalized for emergency treatment were treated with rapamycin (RAPA) in the hospital. A group of manually delineated left ventricular myocardia (LVM) on the patient's coronary computed tomography angiography (CCTA) were selected as the region of interest for imaging features extracted. The CCTA images of 80% of patients were randomly selected for training, and those of 20% of patients were used for verification. The correlation matrix method was used to remove redundant image omics features under different correlation thresholds. In the validation set, CCTA diagnostic parameters were about 40 times higher than the manually segmented data. The average dice similarity coefficient was 91.6%. The proposed method also produced a very small centroid distance (mean 1.058 mm, standard deviation 1.245 mm) and volume difference (mean 1.640), with a segmentation time of about 1.45 ± 0.51 s, compared to about 744.8 ± 117.49 s for physician manual segmentation. Therefore, the deep learning model effectively segmented the atherosclerotic lesion area, measured and assisted the diagnosis of future atherosclerosis clinical cases, improved medical efficiency, and accurately identified the patient's lesion area. It had great application potential in helping diagnosis and curative effect analysis of atherosclerosis.
format Online
Article
Text
id pubmed-8321726
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-83217262021-07-31 Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin Ji, Fuguang Zhou, Shuai Bi, Zhangshuan J Healthc Eng Research Article The clinical characteristics and vascular computed tomography (CT) imaging characteristics of patients were explored so as to assist clinicians in diagnosing patients with atherosclerosis. 316 patients with atherosclerosis who were hospitalized for emergency treatment were treated with rapamycin (RAPA) in the hospital. A group of manually delineated left ventricular myocardia (LVM) on the patient's coronary computed tomography angiography (CCTA) were selected as the region of interest for imaging features extracted. The CCTA images of 80% of patients were randomly selected for training, and those of 20% of patients were used for verification. The correlation matrix method was used to remove redundant image omics features under different correlation thresholds. In the validation set, CCTA diagnostic parameters were about 40 times higher than the manually segmented data. The average dice similarity coefficient was 91.6%. The proposed method also produced a very small centroid distance (mean 1.058 mm, standard deviation 1.245 mm) and volume difference (mean 1.640), with a segmentation time of about 1.45 ± 0.51 s, compared to about 744.8 ± 117.49 s for physician manual segmentation. Therefore, the deep learning model effectively segmented the atherosclerotic lesion area, measured and assisted the diagnosis of future atherosclerosis clinical cases, improved medical efficiency, and accurately identified the patient's lesion area. It had great application potential in helping diagnosis and curative effect analysis of atherosclerosis. Hindawi 2021-07-22 /pmc/articles/PMC8321726/ /pubmed/34336152 http://dx.doi.org/10.1155/2021/4543702 Text en Copyright © 2021 Fuguang Ji et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ji, Fuguang
Zhou, Shuai
Bi, Zhangshuan
Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin
title Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin
title_full Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin
title_fullStr Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin
title_full_unstemmed Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin
title_short Computed Tomography Angiography under Deep Learning in the Treatment of Atherosclerosis with Rapamycin
title_sort computed tomography angiography under deep learning in the treatment of atherosclerosis with rapamycin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321726/
https://www.ncbi.nlm.nih.gov/pubmed/34336152
http://dx.doi.org/10.1155/2021/4543702
work_keys_str_mv AT jifuguang computedtomographyangiographyunderdeeplearninginthetreatmentofatherosclerosiswithrapamycin
AT zhoushuai computedtomographyangiographyunderdeeplearninginthetreatmentofatherosclerosiswithrapamycin
AT bizhangshuan computedtomographyangiographyunderdeeplearninginthetreatmentofatherosclerosiswithrapamycin